Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
50
XBI Quote, Financials, Valuation and Earnings
Last price:
$127.37
Seasonality move
:
-0.29%
Day range:
$125.76 - $127.50
52-week range:
$66.66 - $132.09
Dividend yield:
0.35%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
5.9M
Avg. volume:
8.9M
1-year change:
46.23%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
$127.37 | -- | -- | -- | $0.41 | 0.35% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$208.69 | -- | -- | -- | $1.17 | 0% | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$76.28 | -- | -- | -- | $0.27 | 1.36% | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
$88.40 | -- | -- | -- | $0.02 | 0.08% | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
$108.31 | -- | -- | -- | $0.12 | 0.27% | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
$160.20 | -- | -- | -- | $0.66 | 1.55% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | 0.972 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.393 | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 0.025 | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | 0.802 | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | 0.428 | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -0.123 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- | -- |
State Street SPDR S&P Biotech ETF vs. Competitors
-
Which has Higher Returns XBI or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About XBI or FBT?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe State Street SPDR S&P Biotech ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is XBI or FBT More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.945, which suggesting that the stock is 5.483% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.734, suggesting its less volatile than the S&P 500 by 26.595%.
-
Which is a Better Dividend Stock XBI or FBT?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.35%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0% to investors and pays a quarterly dividend of $1.17 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or FBT?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns XBI or FHLC?
Fidelity MSCI Health Care Index ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat Fidelity MSCI Health Care Index ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- -
What do Analysts Say About XBI or FHLC?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity MSCI Health Care Index ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than Fidelity MSCI Health Care Index ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than Fidelity MSCI Health Care Index ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 FHLCFidelity MSCI Health Care Index ETF0 0 0 -
Is XBI or FHLC More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.945, which suggesting that the stock is 5.483% less volatile than S&P 500. In comparison Fidelity MSCI Health Care Index ETF has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.488%.
-
Which is a Better Dividend Stock XBI or FHLC?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.35%. Fidelity MSCI Health Care Index ETF offers a yield of 1.36% to investors and pays a quarterly dividend of $0.27 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. Fidelity MSCI Health Care Index ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or FHLC?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than Fidelity MSCI Health Care Index ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than Fidelity MSCI Health Care Index ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while Fidelity MSCI Health Care Index ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for Fidelity MSCI Health Care Index ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- FHLCFidelity MSCI Health Care Index ETF-- -- -- --
-
Which has Higher Returns XBI or XHE?
State Street SPDR S&P Health Care Equipment ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About XBI or XHE?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street SPDR S&P Health Care Equipment ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XHEState Street SPDR S&P Health Care Equipment ETF0 0 0 -
Is XBI or XHE More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.945, which suggesting that the stock is 5.483% less volatile than S&P 500. In comparison State Street SPDR S&P Health Care Equipment ETF has a beta of 1.123, suggesting its more volatile than the S&P 500 by 12.312%.
-
Which is a Better Dividend Stock XBI or XHE?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.35%. State Street SPDR S&P Health Care Equipment ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.02 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHE?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Equipment ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street SPDR S&P Health Care Equipment ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns XBI or XHS?
State Street SPDR S&P Health Care Services ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street SPDR S&P Health Care Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XHSState Street SPDR S&P Health Care Services ETF-- -- -- -
What do Analysts Say About XBI or XHS?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street SPDR S&P Health Care Services ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street SPDR S&P Health Care Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XHSState Street SPDR S&P Health Care Services ETF0 0 0 -
Is XBI or XHS More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.945, which suggesting that the stock is 5.483% less volatile than S&P 500. In comparison State Street SPDR S&P Health Care Services ETF has a beta of 1.030, suggesting its more volatile than the S&P 500 by 2.953%.
-
Which is a Better Dividend Stock XBI or XHS?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.35%. State Street SPDR S&P Health Care Services ETF offers a yield of 0.27% to investors and pays a quarterly dividend of $0.12 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XHS?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Services ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street SPDR S&P Health Care Services ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street SPDR S&P Health Care Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XHSState Street SPDR S&P Health Care Services ETF-- -- -- --
-
Which has Higher Returns XBI or XLV?
State Street Health Care Select Sector SPDR ETF has a net margin of -- compared to State Street SPDR S&P Biotech ETF's net margin of --. State Street SPDR S&P Biotech ETF's return on equity of -- beat State Street Health Care Select Sector SPDR ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XBIState Street SPDR S&P Biotech ETF-- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- -
What do Analysts Say About XBI or XLV?
State Street SPDR S&P Biotech ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street Health Care Select Sector SPDR ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Biotech ETF has higher upside potential than State Street Health Care Select Sector SPDR ETF, analysts believe State Street SPDR S&P Biotech ETF is more attractive than State Street Health Care Select Sector SPDR ETF.
Company Buy Ratings Hold Ratings Sell Ratings XBIState Street SPDR S&P Biotech ETF0 0 0 XLVState Street Health Care Select Sector SPDR ETF0 0 0 -
Is XBI or XLV More Risky?
State Street SPDR S&P Biotech ETF has a beta of 0.945, which suggesting that the stock is 5.483% less volatile than S&P 500. In comparison State Street Health Care Select Sector SPDR ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.438%.
-
Which is a Better Dividend Stock XBI or XLV?
State Street SPDR S&P Biotech ETF has a quarterly dividend of $0.41 per share corresponding to a yield of 0.35%. State Street Health Care Select Sector SPDR ETF offers a yield of 1.55% to investors and pays a quarterly dividend of $0.66 per share. State Street SPDR S&P Biotech ETF pays -- of its earnings as a dividend. State Street Health Care Select Sector SPDR ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XBI or XLV?
State Street SPDR S&P Biotech ETF quarterly revenues are --, which are smaller than State Street Health Care Select Sector SPDR ETF quarterly revenues of --. State Street SPDR S&P Biotech ETF's net income of -- is lower than State Street Health Care Select Sector SPDR ETF's net income of --. Notably, State Street SPDR S&P Biotech ETF's price-to-earnings ratio is -- while State Street Health Care Select Sector SPDR ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Biotech ETF is -- versus -- for State Street Health Care Select Sector SPDR ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XBIState Street SPDR S&P Biotech ETF-- -- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Feb 28
Applied Optoelectronics, Inc. [AAOI] is up 56.96% over the past day.
Buy
90
BNAI alert for Feb 28
Brand Engagement Network, Inc. [BNAI] is up 36.02% over the past day.
Sell
36
WLDN alert for Feb 28
Willdan Group, Inc. [WLDN] is down 25.56% over the past day.
